Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Therapies02:49

Cancer Therapies

8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating a Tailored Web-Based eHealth Intervention for Symptom Management in Couples Managing Prostate Cancer During the COVID-19 Pandemic: Randomized Clinical Trial.

Journal of medical Internet research·2026
Same author

Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer.

The Prostate·2026
Same author

Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors.

Pharmacoepidemiology and drug safety·2026
Same author

Biologically Effective Dose-Optimized Multi-Intensity-Modulated Proton Therapy: A Biologically Comparable Alternative to Proton Arc Therapy.

International journal of particle therapy·2026
Same author

Lattice peak optimization: a mixed-integer framework for geometry-adaptive lattice radiotherapy.

Physics in medicine and biology·2026
Same author

Spatial Dosimetric-Based Prediction of Long-Term Urinary Toxicity After Permanent Prostate Brachytherapy.

Cancers·2026

相关实验视频

Updated: May 2, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

通过时空优化优化优化正常组织的节约,在同等的瘤根基疗效下.

Nimita Shinde1, Wangyao Li2, Ronald C Chen3

  • 1Department of Radiation Oncology, The University of Kansas Medical Center, 4001 Rainbow Blvd, Kansas City, Kansas, 66160-8500, UNITED STATES.

Physics in medicine and biology
|June 13, 2025
PubMed
概括

这项研究引入了一种用于放射治疗的新型时空优化模型,确保足够的瘤细胞死亡,同时尽量减少对健康器官的剂量. 该模型优化了基于瘤生长动态的辐射分离,以进行个性化治疗规划.

关键词:
生物有效剂量 (BED)强度调制的质子疗法 (IMPT)空间时间优化优化

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

相关实验视频

Last Updated: May 2, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K

科学领域:

  • 辐射瘤学 辐射瘤学
  • 医学物理 医学物理
  • 计算生物学 计算生物学

背景情况:

  • 传统的辐射疗法优化最大限度地提高了瘤剂量,但可能会损害瘤的死亡.
  • 时空优化旨在平衡目标剂量和危险器官 (OAR) 的节约.
  • 瘤增殖动态 (延迟时间,翻倍时间) 显著影响治疗结果.

研究的目的:

  • 为质子疗法开发一个时空优化模型.
  • 确保足够的生物有效剂量 (BED) 杀死瘤细胞.
  • 为了最大限度地减少BED交付给OARs,考虑到瘤的扩散.

主要方法:

  • 为质子疗法制定了一种新的时空优化模型.
  • 纳入一个不平等约束,以保证足够的瘤BED.
  • 考虑了瘤滞后时间和剂量分数优化中的翻倍时间.

主要成果:

  • 该模型在经过测试的场景中始终满足瘤细胞杀伤的最低BED要求.
  • 平均BED到OAR随着瘤扩散动态而变化.
  • 确定了前列腺 (大约) 的最佳分成策略. 20个分数) 和头部和部病例.

结论:

  • 拟议的模型有效地确定了最佳的辐射分离策略.
  • 它最大限度地降低了OAR剂量,同时确保了瘤细胞的杀死,根据瘤生长率进行个性化.
  • 这种方法为先进的临床治疗规划提供了一种多功能工具.